GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AWH
Aspira is a company specializing in ovarian cancer diagnostics. Its stock price reflects its efforts to introduce its tests into clinical practice. The chart tells the story of its struggle for recognition from doctors and insurance companies.
Share prices of companies in the market segment - Medanalysis
Aspira Women's Health develops and markets diagnostic tests to assess the risk of ovarian cancer in women. We've categorized it as a "Medanalysis" company. The chart below shows how the market values companies working in women's health and cancer diagnostics.
Broad Market Index - GURU.Markets
Aspira Women's Health is a diagnostics company developing tests for gynecological cancer detection. As a component of the GURU.Markets index, it represents the women's health sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AWH - Daily change in the company's share price AWH
Aspira Women's Health's daily share price fluctuations reflect the volatility of the medical diagnostics sector. This indicator measures the sensitivity of the company's tests for identifying cancer risks in women.
Daily change in the price of a set of shares in a market segment - Medanalysis
Aspira Women's Health develops diagnostic tests to assess the risk of ovarian cancer. The oncology diagnostics sector is extremely sensitive to clinical data and regulatory approvals. The chart below shows the volatility in this niche, reflecting both high expectations and risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Aspira Women's Health specializes in ovarian cancer diagnostics. The company's shares are reacting to news of its tests being accepted by the medical community. This specific volatility, driven by medical innovation, feeds into the overall market movement.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AWH
Aspira Women's Health's year-over-year performance tells the story of its work in the ovarian cancer diagnostics market. Its market cap growth over the past 12 months reflects its success in promoting its Ova1Plus® tests, which help doctors assess the risk of malignant tumors. Its valuation reflects its bet that its tests will become the standard in gynecology.
Annual dynamics of market capitalization of the market segment - Medanalysis
Aspira, a company developing cancer diagnostic tests, is betting on medical innovation. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique technology and secure regulatory approval.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aspira Women's Health, a company specializing in ovarian cancer diagnostics, is working to address a significant issue in women's health. Its year-over-year market capitalization reflects the success of its tests in clinical practice and insurance coverage.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AWH
Aspira is a company specializing in ovarian cancer diagnostics. Its monthly growth depends on increasing testing volumes and securing insurance reimbursement for its tests, which is key to widespread adoption.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Aspira Women's Health specializes in diagnostic tests for gynecological diseases, including ovarian cancer. The molecular diagnostics sector in women's health is rapidly growing. The chart below shows how investors assessed the potential of new early detection tests, which could save thousands of lives.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aspira Women's Health specializes in ovarian cancer diagnostics. Its success depends on how widely its tests are used by doctors and covered by insurance. Share price performance reflects progress in commercialization and serves as a barometer for the adoption of new technologies in women's health.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AWH
Shares of Aspira Women's Health, a company specializing in ovarian cancer diagnostics, are news-sensitive. Weekly price movements depend on test volume data, insurance company decisions, and regulatory announcements. The chart below shows how short-term developments in this important healthcare niche impact the company's valuation.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Aspira Women's Health specializes in diagnostic tests for ovarian cancer. Its success depends on the adoption of these tests in clinical practice. The chart below shows how news of its tests' acceptance by the medical community impacts its stock, distinguishing it from the medical diagnostics sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Aspira Women's Health operates in the medical diagnostics sector. This chart compares its weekly performance to the broader market. It helps understand how resilient its business, which focuses on basic healthcare needs, is to general economic downturns.
Market capitalization of the company, segment and market as a whole
AWH - Market capitalization of the company AWH
Aspira Women's Health's market capitalization reflects its focus on diagnosing gynecological conditions, particularly ovarian cancer. The company's valuation depends on how widely its tests are adopted by doctors. The chart below shows how investors assess its chances of creating a new standard in women's health.
AWH - Share of the company's market capitalization AWH within the market segment - Medanalysis
Aspira Women's Health's market share in the medical analysis sector reflects its focus on ovarian cancer diagnostics. Its market share stems from the strength of its tests, which help physicians assess the risk of malignant tumors in women, a crucial task in gynecology.
Market capitalization of the market segment - Medanalysis
This chart shows the total market capitalization of companies engaged in women's health diagnostics. Aspira Women's Health is one such player. The dynamics in the chart reflect how the market values new tests and technologies aimed at early cancer detection.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market value of early ovarian cancer detection. Aspira Women's Health's market value is determined by the value of its biomarker-based tests. The line shows how technologies targeting women's health are competing for their share of the global preventive healthcare economy.
Book value capitalization of the company, segment and market as a whole
AWH - Book value capitalization of the company AWH
Aspira Women's Health's book value represents its scientific capital. The chart below reflects the valuation of its patent portfolio for diagnostic tests (OvaWatch, Ova1) for ovarian cancer risk assessment. The line's growth signals success in commercialization and the development of new tests for women's health.
AWH - Share of the company's book capitalization AWH within the market segment - Medanalysis
Aspira Women's Health's core assets are its laboratories, where diagnostic tests for ovarian cancer are performed. The chart shows the company's share of this specialized medical infrastructure, which forms the physical basis for its diagnostic services.
Market segment balance sheet capitalization - Medanalysis
Amid the capital-intensive pharmaceutical industry, Aspira Women's Health has chosen the diagnostics industry. Its business requires a unique yet focused resource base—laboratories for its testing. The chart illustrates the scale of the industry in which Aspira occupies its high-tech niche.
Book value of all companies included in the broad market index - GURU.Markets
Aspira Women's Health specializes in diagnosing ovarian cancer and other gynecological conditions. The company's assets include certified laboratories that perform their unique blood tests. The chart below illustrates the company's significant role in women's health.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AWH
Aspira Women's Health develops diagnostic tests for women's health, specifically for ovarian cancer detection. Its value lies in its technology and data. The chart below shows how the market perceives the commercial potential of its tests and their potential to become a standard in gynecology.
Market to book capitalization ratio in a market segment - Medanalysis
Aspira Women's Health Inc. develops diagnostic tests for gynecological conditions. Its value lies in the accuracy and uniqueness of its tests. This chart shows how its market valuation, reflecting the commercial potential of its products, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer. This chart shows how the market views their technology and its potential to improve early detection. The market dynamics depend on testing volumes and new research findings.
Debts of the company, segment and market as a whole
AWH - Company debts AWH
Aspira Women's Health, a company specializing in ovarian cancer diagnostics, is leveraging its financial structure to commercialize its tests. This chart shows how the company is investing in its sales force and laboratory capacity to convince doctors and insurers of the value of its diagnostic products.
Market segment debts - Medanalysis
Aspira Women's Health develops and commercializes diagnostic tests for ovarian cancer. This chart shows how its debt policy reflects the investments required to conduct clinical trials, obtain approval, and, most challenging of all, convince doctors and insurers to use its tests.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AWH
AERWINS Technologies, a developer of flying motorcycles and drones, operates at the cutting edge of technology. This futuristic business requires massive R&D investments with uncertain commercial prospects. The chart illustrates the high financial risk the company is taking to bring its bold ideas to life.
Market segment debt to market segment book capitalization - Medanalysis
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer risk assessment. This chart compares its debt load to the overall market capitalization of the sector. It shows how the company funds the commercialization of its products and research to expand their use.
Debt to book value of all companies in the market
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer. Early detection in oncology saves lives. This graph of total market debt helps understand the financial environment in which Aspira is raising capital to advance its tests and conduct research to make them the standard of care.
P/E of the company, segment and market as a whole
P/E - AWH
This chart shows the valuation of Aspira Women's Health, a gynecological diagnostics company. The price-to-earnings ratio (if any) will reflect the demand for its tests. This is a bet that its diagnostic solutions will help doctors identify risks earlier and more accurately, becoming the standard in their field.
P/E of the market segment - Medanalysis
Aspira Women's Health specializes in the development and commercialization of diagnostic tests for ovarian cancer risk assessment. Their tests help physicians make decisions about the management of patients with pelvic tumors. This chart shows the average rating for the medical analysis sector, reflecting how the market values innovations in early cancer detection.
P/E of the market as a whole
Aspira Women's Health develops and markets biomarker-based diagnostic tests that help assess the risk of ovarian cancer in women with pelvic tumors. This sentiment chart helps understand how investors value companies in the women's health and cancer diagnostics space.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AWH
Aspira Women's Health is a company specializing in diagnosing ovarian cancer and other gynecological conditions. This chart shows its expected future revenue, which depends on the clinical adoption of its diagnostic tests and insurance reimbursement.
%20P%2FE%20AWH&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-AWH&v=1772511730875 "Chart of the company's future (projected) P/E AWH")
Future (projected) P/E of the market segment - Medanalysis
Aspira Women's Health develops and markets diagnostic tests to detect ovarian cancer risks. This chart shows how investors assess the commercial potential of its products. It compares expectations for Aspira with other companies in the medical diagnostics sector, demonstrating confidence in its technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772511730901 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Aspira Women's Health specializes in diagnostic tests for early ovarian cancer detection. Demand for their products depends on their adoption in clinical practice. The overall economic backdrop, illustrated in this graph, impacts healthcare budgets and the willingness of physicians and patients to use new, more accurate diagnostic methods.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772511730904 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit AWH
Aspira Women's Health specializes in diagnostic tests for ovarian cancer. Its revenue depends on the number of tests performed and reimbursement rates. This chart shows the company's financial trajectory as it strives to make its tests the standard in gynecological practice for the early detection of cancer.
Profit of companies in the market segment - Medanalysis
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer risk assessment. This graph, showing overall sector profitability, reflects the importance of early detection in oncology. The success of Aspira's tests in improving diagnostic accuracy directly impacts treatment outcomes and the profitability of the entire medical testing industry.
Overall market profit
Aspira Women's Health specializes in diagnostic tests for ovarian cancer. Early detection is key to successful treatment, and the company strives to provide doctors with more accurate tools for assessing their patients' risk.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AWH
Aspira Women's Health specializes in diagnostic tests for ovarian cancer risk assessment. Future revenue projections depend on testing volumes and the inclusion of its products in clinical guidelines and insurance coverage.
%20profit%20of%20the%20company%20AWH&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-AWH&v=1772511730993 "Graph of future (projected) profit of the company AWH")
Future (predicted) profit of companies in the market segment - Medanalysis
Aspira Women's Health specializes in developing diagnostic tests for ovarian cancer risk assessment. This chart reflects revenue expectations for the entire healthcare analytics sector. It allows one to assess how the company's products, aimed at early detection in this critical area of women's health, compare to overall trends in cancer diagnostics.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772511731080 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Aspira Women's Health develops diagnostic tests for women's health, specifically for ovarian cancer detection. Demand for these tests is growing as awareness increases. This schedule is important because during periods of economic growth, healthcare systems and insurance companies are more willing to expand coverage for new diagnostic procedures, which benefits Aspira.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772511731162 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - AWH
Aspira Women's Health specializes in developing diagnostic tests for gynecological diseases, including ovarian cancer. This market cap-to-revenue multiple reflects its efforts to commercialize its tests. It shows how investors view its scientific platform and its ability to increase physician utilization of the tests.
P/S market segment - Medanalysis
Aspira Women's Health specializes in the development and commercialization of diagnostic tests for ovarian cancer risk assessment. The company's products help doctors make more informed treatment decisions. This chart shows how the market values revenue in the medical diagnostics sector, which helps understand how investors value Aspira's products and their role in women's health.
P/S of the market as a whole
Aspira Women's Health develops and commercializes diagnostic tests to assess the risk of ovarian cancer in women. This chart shows how the market values companies in the women's health and cancer diagnostics sector compared to average market multiples.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AWH
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer risk assessment. This chart shows how investors value the company based on its projected future test revenue. It reflects their belief in the growing demand for early diagnosis and the widespread adoption of its products.
%20P%2FS%20AWH&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-AWH&v=1772511731257 "The graph of the company's future (projected) P/S AWH")
Future (projected) P/S of the market segment - Medanalysis
Aspira Women's Health specializes in the development and commercialization of diagnostic tests for ovarian cancer risk assessment. The chart reflects the average estimated future revenue for the medical diagnostics sector. It helps understand how the market views Aspira's diagnostic products and their potential to improve the early detection of this dangerous disease.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772511731277 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Aspira Women's Health (AWH) develops and markets diagnostic tests for ovarian cancer. Demand for their products is driven by the need for early detection and is not affected by economic cycles. This graph does not reflect their potential to improve women's health and fight cancer.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772511731295 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales AWH
Aspira Women's Health's revenue is generated by sales of its ovarian cancer diagnostic tests. These blood-based tests help doctors assess a woman's risk of developing malignant tumors. This growth reflects increased testing volumes and the acceptance of its technology in gynecological practice.
Sales of companies in the market segment - Medanalysis
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer risk assessment. Its revenue breakdown reflects the split between its flagship Ova1 test and other products. This reflects its focus on solving complex women's health problems using proteomics.
Overall market sales
Aspira Women's Health Inc. specializes in diagnostic tests for ovarian cancer. Demand for its products depends on the adoption of its tests in clinical practice. The overall economic situation, shown in this graph, influences healthcare costs and the system's willingness to implement new, more advanced, but potentially more expensive diagnostic methods.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AWH
Aspira Women's Health develops diagnostic tests to assess the risk of ovarian cancer. The company's sales depend on the number of tests performed and reimbursement rates. This chart shows analyst expectations for the gynecological diagnostics market.
%20sales%20of%20the%20company%20AWH&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-AWH&v=1772511731398 "Schedule of future (projected) sales of the company AWH")
Future (projected) sales of companies in the market segment - Medanalysis
Aspira Women's Health specializes in diagnostic tests for ovarian cancer detection and gynecological risk assessment. This chart shows the outlook for the healthcare analytics sector. It reflects the need for early and accurate cancer diagnosis, which can significantly improve treatment outcomes for women.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772511731448 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Healthcare cost forecasts, which are part of the overall expectations in this chart, are important for Aspira Women's Health. The company develops diagnostic tests for gynecological conditions. The introduction of these new tests into clinical practice depends on their approval and the willingness of insurance companies to cover the costs.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772511731478 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality AWH
Aspira Women's Health develops and markets diagnostic tests for ovarian cancer risk assessment. This chart shows profitability in the medical diagnostics sector. Profitability depends on the number of tests performed, reimbursement rates, and the successful introduction of new products to improve women's health.
Market segment marginality - Medanalysis
Aspira Women's Health specializes in the development and sale of diagnostic tests for gynecological diseases, particularly ovarian cancer. Profitability depends on the widespread adoption of its tests in clinical practice. This chart shows the average profitability in the sector, helping to assess the commercial potential of its diagnostic solutions.
Market marginality as a whole
Aspira Women's Health specializes in diagnostic tests for gynecological conditions, including ovarian cancer. Demand for its tests depends on their inclusion in clinical guidelines and insurance coverage. This dynamic, reflecting the state of the economy, impacts the healthcare system and the willingness of payers to cover the costs of new, more advanced diagnostic methods.
Employees in the company, segment and market as a whole
Number of employees in the company AWH
Aspira Women's Health specializes in diagnostic tests for gynecological conditions, including ovarian cancer. This chart reflects the size of the team dedicated to research, laboratory analysis, and sales. The trend shows the company's efforts to introduce its tests into clinical practice and increase their use.
Share of the company's employees AWH within the market segment - Medanalysis
Aspira Women's Health specializes in ovarian cancer risk assessment using its biomarker-based tests. This chart shows the company's share of the total number of employees in the medical diagnostics sector. This reflects its focus on women's health and its role in early cancer detection.
Number of employees in the market segment - Medanalysis
Aspira Women's Health Inc. specializes in the development and commercialization of diagnostic tests for assessing the risk of gynecological diseases, such as ovarian cancer. This chart, showing employment in the medical analytics sector, is important. The growth in women's health specialists reflects the desire for early diagnosis and personalized care.
Number of employees in the market as a whole
Aspira Women's Health develops diagnostic tests for gynecological cancer detection. This employment rate chart reflects the number of women with access to regular medical screenings. Having company-sponsored insurance, which is linked to a stable job, is a key factor in obtaining preventive screenings and using advanced tests.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AWH (AWH)
Aspira Women's Health (AWH) is a company specializing in ovarian cancer diagnostics (the Ova1 test). In the medical diagnostics sector, this metric reflects the value of the technology. The company's value lies in its patents and the data that help doctors make diagnoses. This is a high valuation of "intellectual capital."
%20of%20the%20company%20AWH%20(AWH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-AWH-AWH&v=1772511731586 "Chart of market capitalization per employee (in thousands of dollars) of the company AWH (AWH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Aspira Women's Health develops diagnostic tests for gynecological diseases, including ovarian cancer. It's a knowledge-intensive business, where R&D and test accuracy drive the company's value. This metric helps understand how highly the market values the company's intellectual capital and product potential per employee.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772511731590 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Aspira Women's Health specializes in diagnostic tests for gynecological conditions, particularly ovarian cancer. In medical diagnostics, value is determined by accuracy and clinical benefit. This metric reflects how the market perceives the potential of its tests to become a standard in women's health care.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772511731605 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AWH (AWH)
Aspira Women's Health specializes in ovarian cancer diagnostics (Ova1 tests). It's a niche medtech business. This chart shows how successfully their commercial team and laboratory generate revenue from sales of these diagnostic tests, balancing R&D with promotional costs among physicians.
%20Chart%20AWH%20(AWH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-AWH-AWH&v=1772511731616 "Company Profit Per Employee (in thousands of dollars) Chart AWH (AWH)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Aspira Women's Health develops and commercializes diagnostic tests for ovarian cancer. This chart shows the company's success in marketing its tests. High profitability per employee in the medical diagnostics sector is achieved through unique and accurate technology, which is becoming a standard in medical practice.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772511731620 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Aspira Women's Health (AWH) is a company specializing in ovarian cancer diagnostics (blood tests) (Ova1, OvaWatch). It is a MedTech diagnostics company. This chart shows how a company with a commercial but niche diagnostic product generates revenue from its staff (lab technicians, salespeople).
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772511731635 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee AWH (AWH)
Aspira Women's Health develops diagnostic tests for gynecological conditions. This chart shows how the company is commercializing its products. Increasing revenue per employee will mean increasing the number of tests performed and recognition of their value in the medical community.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-AWH-AWH&v=1772511731651 "Sales chart per company employee AWH (AWH)")
Sales per employee in the market segment - Medanalysis
Aspira Women's Health develops and markets diagnostic tests (Ova1) for assessing the risk of ovarian cancer in women. They are a business-to-business (B2B) diagnostic company. This chart demonstrates the productivity of their laboratory and sales teams. It reflects their ability to process tests and convince doctors to use their risk assessment algorithm.
Sales per employee for the market as a whole
Trinity Capital (TRIN) is a business development company (BDC) that provides venture debt financing (loans) to high-growth, venture-backed startups. This chart reflects their niche. Like other BDCs, Trinity has a small staff of highly qualified investors managing its loan portfolio. High revenue per employee is the norm here, as it's a wealth management business.
Short shares by company, segment and market as a whole
Shares shorted by company AWH (AWH)
Aspira Women's Health (AWH) develops diagnostic tests for women's health (such as ovarian cancer). This chart shows the number of short positions. Bears doubt the company's tests will be widely accepted by doctors and insurers, and the company remains deeply unprofitable.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-AWH-AWH&v=1772511731720 "Short Shares Chart for the Company AWH (AWH)")
Shares shorted by market segment - Medanalysis
Aspira Women's Health (AWH) specializes in diagnostic tests for women's health, particularly the early detection of ovarian cancer. The chart below shows the overall short position in the medical diagnostics sector. It reflects the investor confidence in the commercial success of these tests.
Shares shorted by the overall market
Aspira (AWH) is an R&D company developing cancer diagnostics. It's a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks like AWH, whose fate depends on R&D and regulatory approval.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AWH (AWH)
This oscillator for Aspira is a barometer of demand for ovarian cancer diagnostics. The company sells tests (OvaWatch) that help assess cancer risk before surgery. "Overbought" levels (above 70) arise from news of an increase in testing. Slow adoption by doctors and competition lead to "oversold" levels (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-AWH-AWH&v=1772511731751 "RSI 14 indicator chart for the company's stock AWH (AWH)")
RSI 14 Market Segment - Medanalysis
Aspira is a "diagnostic" company for *women*. Their specialty is *blood tests* (OvaWatch, Ova1), which *assess the risk* of *ovarian* cancer. The "Medanalysis" (diagnostic) sector thrives on R&D. RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is AWH's growth a niche or a general "hype"?
RSI 14 for the overall market
Aspira Women's Health (AWH), a cash-burning biotech, is on the rise. This chart is its lifeline. During periods of market euphoria, investors are willing to "buy the dream" and fund unprofitable R&D projects. During moments of panic, the cash spigot is turned off, and investors demand profits, not promises, which puts AWH at risk of survival.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AWH (AWH)
Aspira Women's Health (AWH) is a company focused on women's health. They offer diagnostic tests (OvaWatch, Ova1) for assessing ovarian cancer risk. This chart shows the analysts' average 12-month forecast, reflecting their view on how quickly these tests will be adopted into gynecological practice.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AWH-AWH&v=1772511731767 "A chart showing analyst consensus forecasts for the expected stock price. AWH (AWH)")
The difference between the consensus estimate and the actual stock price AWH (AWH)
Aspira (AWH) stands for "women's health." The company develops and markets diagnostic tests (Ova1/OvaWatch) that help assess the risk of ovarian cancer in women. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the adoption of these tests in gynecology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AWH-AWH&v=1772511731776 "A chart showing the difference between the consensus forecast and the actual stock price. AWH (AWH)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Aspira Women's Health (AWH) is a diagnostic company focused on women's health. Its tests (OvaWatch) help assess the risk of ovarian cancer in women with cysts. This chart shows general expectations for the medical testing sector. It reflects whether experts believe the predictive diagnostics market in gynecology will grow.
Analysts' consensus forecast for the overall market share price
Aspira Women's Health (AWH) is a company focused on ovarian health. They have developed diagnostic tests (Ova1) that use blood tests to assess cancer risk. This chart shows the general sentiment of experts. It reflects the level of confidence analysts have in the stability of the healthcare system and its willingness to pay for (reimburse) new, expensive tests.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AWH
Aspira is a women's health alarm system. Their signature feature is their diagnostic tests (OvaWatch, Ova1), which use AI and blood analysis to assess the risk of ovarian cancer (rather than diagnose it) in women with cysts. This chart summarizes their implementation history. It reflects their (slow) growth in testing volumes and their (difficult) path to reimbursement.
AKIMA Market Segment Index - Medanalysis
Aspira Women's Health specializes in women's health. They have developed diagnostic tests (Ova1) that help doctors assess the risk of ovarian cancer in patients with tumors. This graph compares their composite index to the sector, showing how their women's media analytics outperforms the competition.
The AKIM Index for the overall market
Aspira Women's Health is a diagnostic company specializing in gynecology (Ova1 ovarian cancer tests). This chart, reflecting the market average, is a backdrop. It helps assess how AWH, which is working to roll out its tests, compares to overall macroeconomic fluctuations.
